12 hours ago
The risk of ischemia heart disease was significantly higher in the SLE cohort when compared with controls, with risks peaking between the 6th and 9th year post-diagnosis.
13 hours ago
An analysis based in Japan suggests ranibizumab biosimilar is dominant to other anti-VEGF treatments in patients with nAMD in both treat-and-extend and PRN regimens.
14 hours ago
In recent years, the field of endophenotyping has garnered significant attention in sleep health, signaling a growing recognition of the need to move beyond simplistic measures.
15 hours ago
The rheumatology month in review highlights a program developed by Janssen to support health equity, the increased risks pregnant women with rheumatic diseases face, and trends in fibromyalgia management.
16 hours ago
Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, provide their recommendations for clinicians who are taking care of patients with rare dermatological disorders in the critical care setting.